Pharmacological treatment of acute-phase anorexia nervosa: Evidence from randomized controlled trials

Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant

(2017) Magdalena Sowa-Kućma et al.   Pharmacological Reports

Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs

(2017) M Lancee et al.   Translational Psychiatry

Medical Complications of Anorexia Nervosa and Bulimia

(2016) Patricia Westmoreland et al.   AMERICAN JOURNAL OF MEDICINE

The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects

(2016) Guido K. W. Frank et al.   CNS DRUGS

Epidemiology of eating disorders in Europe

(2016) Anna Keski-Rahkonen et al.   CURRENT OPINION IN PSYCHIATRY

Recovery From Anorexia Nervosa and Bulimia Nervosa at 22-Year Follow-Up

(2016) Kamryn T. Eddy et al.   JOURNAL OF CLINICAL PSYCHIATRY

Psychopharmacological options for adult patients with anorexia nervosa

(2015) Mario Miniati et al.   CNS SPECTRUMS

Psychiatric comorbidity in women and men with eating disorders results from a large clinical database

(2015) Sara Ulfvebrand et al.   PSYCHIATRY RESEARCH

A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD

(2015) Atul R. Mahableshwarkar et al.   PSYCHOPHARMACOLOGY

Second-Generation Antipsychotic Drugs in Anorexia Nervosa: A Meta-Analysis of Randomized Controlled Trials

(2015) Markus Dold et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Lack of efficacy of psychological and pharmacological treatments of disorders of eating behavior: neurobiological background

(2014) Francesca Brambilla et al.   BMC Psychiatry

An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial

(2014) Suresh Durgam et al.   SCHIZOPHRENIA RESEARCH

The neurobiology of anorexia nervosa: A systematic review

(2013) Andrea Phillipou et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Long-term safety and tolerability of lurasidone in schizophrenia

(2012) Leslie Citrome et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Mortality Rates in Patients With Anorexia Nervosa and Other Eating Disorders

(2011) Jon Arcelus   ARCHIVES OF GENERAL PSYCHIATRY

A Placebo-Controlled Pilot Study of Adjunctive Olanzapine for Adolescents with Anorexia Nervosa

(2011) Vivian Kafantaris et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

A Double-Blind, Placebo-Controlled Study of Risperidone for the Treatment of Adolescents and Young Adults with Anorexia Nervosa: A Pilot Study

(2011) Jennifer Hagman et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Olanzapine versus placebo for out-patients with anorexia nervosa

(2011) E. Attia et al.   PSYCHOLOGICAL MEDICINE

Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder

(2011) Steven G. Potkin et al.   SCHIZOPHRENIA RESEARCH

Investigating the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people: A pilot study

(2010) Andrew Court et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Factors associated with dropout from treatment for eating disorders: a comprehensive literature review

(2009) Secondo Fassino et al.   BMC Psychiatry

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Olanzapine in the Treatment of Low Body Weight and Obsessive Thinking in Women With Anorexia Nervosa: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Hany Bissada et al.   AMERICAN JOURNAL OF PSYCHIATRY